 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Intellipharmaceutics International stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy OTC:IPCIF! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Intellipharmaceutics International stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; and Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression. It also provides Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Pristiq, a desvenlafaxine extended-release tablet to treat depression; and Regabatin and Lyrica, a pregabalin extended-release capsule for the management of neuropathic pain. In addition, the company offers Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Oleptro, a trazodone hydrochloride extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Ranexa, a ranolazine extended release tablet for chronic angina. Further, it is developing Oxycodone ER, an extended release tablet for relief of pain. The company has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.
Average volume
84,688 shs
MARKET CAP
$7.10 million
Stock exchange
OTCMKTS
Buy this stock!
|
NAME
|
TICKER
|
INDUSTRY
|
SECTOR
|
VOLUME
|
BUY THIS STOCK NOW
|
|---|---|---|---|---|---|
|
OTCMKTS:IPCIF
|
Pharmaceutical preparations
|
Medical
|
538,000 shs
|
Below is a quick guide on how to buy OTC:IPCIF stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Intellipharmaceutics International shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Intellipharmaceutics International – Search for “”OTC:IPCIF”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Intellipharmaceutics International stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Wall Street analysts have given Intellipharmaceutics International a “N/A” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Intellipharmaceutics International wasn’t one of them. Reportlab thinks these five stocks may be even better buys.
Intellipharmaceutics International is scheduled to release its next quarterly earnings announcement on Friday, February 26th 2021.
View our earnings forecast for Intellipharmaceutics International.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing OTC:IPCIF stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Intellipharmaceutics International stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Intellipharmaceutics International stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “OTC:IPCIF stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some OTC:IPCIF stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, OTC:IPCIF is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Intellipharmaceutics International stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) released its quarterly earnings results on Monday, July, 16th. The company reported ($0.70) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.70). The firm had revenue of $0.58 million for the quarter, compared to analysts’ expectations of $0.90 million.
View Intellipharmaceutics International’s earnings history.
Intellipharmaceutics International’s stock was trading at $0.1201 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IPCIF shares have increased by 149.8% and is now trading at $0.30.
Intellipharmaceutics International shares reverse split before market open on Friday, September 14th 2018. The 1-10 reverse split was announced on Thursday, September 13th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 13th 2018. An investor that had 100 shares of Intellipharmaceutics International stock prior to the reverse split would have 10 shares after the split.
Intellipharmaceutics International saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 9,800 shares, an increase of 58.1% from the December 15th total of 6,200 shares. Based on an average trading volume of 21,500 shares, the short-interest ratio is currently 0.5 days.
View Intellipharmaceutics International’s Short Interest.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying OTC:IPCIF stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Intellipharmaceutics International’s management team includes the following people:
Dr. Isa Odidi M.B.A., Ph.D., MBA, Co-Founder, Chairman, CEO & Co-Chief Scientific Officer (Age 63, Pay $455.71k)
Dr. Amina Odidi, Pres, COO, Co-Chief Scientific Officer, Acting CFO & Director (Age 61, Pay $455.71k)
Fazayill Shaideen, Controller
Some companies that are related to Intellipharmaceutics International include Q BioMed (QBIO), Provectus Biopharmaceuticals (PVCT), Integrated BioPharma (INBP), Pharmaxis (PXSLY), China SXT Pharmaceuticals (SXTC), Mateon Therapeutics (MATN), RespireRx Pharmaceuticals (RSPI), Vicapsys Life Sciences (VICP), MusclePharm (MSLP), GeoVax Labs (GOVX), Abliva AB (publ) (NEVPF), Bellicum Pharmaceuticals (BLCM), Auris Medical (EARS), Teligent (TLGT) and Eledon Pharmaceuticals (ELDN).
View all of IPCIF’s competitors.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Intellipharmaceutics International trades on the OTCMKTS under the ticker symbol “IPCIF.”
Shares of IPCIF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
One share of IPCIF stock can currently be purchased for approximately $0.30.
Intellipharmaceutics International has a market capitalization of $7.10 million and generates $3.48 million in revenue each year.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Intellipharmaceutics International employs 33 workers across the globe.
The official website for Intellipharmaceutics International is www.intellipharmaceutics.com.
Intellipharmaceutics International is headquartered at 30 WORCESTER ROAD, TORONTO A6, M9W 5X2.
Intellipharmaceutics International’s mailing address is 30 WORCESTER ROAD, TORONTO A6, M9W 5X2. The company can be reached via phone at 416-798-3001 or via email at investors@intellipharmaceutics.com
At reportlab we want to help you with a detailed stock analysis, we want to remind you that the data provided on this website is not necessarily entirely current or accurate. The data and quotes on the website are not always provided by a market or exchange, but may also come from market makers. Therefore, the quotes may not be accurate and may differ from the actual price on a market. They are indicative quotes and are not suitable for trading purposes.
At Reportlab.org we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How to buy Intellipharmaceutics International stock?
The safest and easiest way to buy OTC:IPCIF stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Opening an account with one of these brokers is a smart move, they have been active for more then 10 years, are very safe to use and they have the best platform for novice and experienced traders. If you want to learn more then we suggest you to read our eToro or DeGiro guides.
Where to buy Intellipharmaceutics International stock?
You will first want to find a licensed broker that supports OTC:IPCIF stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading OTC:IPCIF stocks in a safe and complete environment.
Is OTC:IPCIF stock a good investment?
As with any other asset, there is an element of risk associated with buying OTC:IPCIF stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Intellipharmaceutics International stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with OTC:IPCIF is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Intellipharmaceutics International stock.
How do you trade Intellipharmaceutics International stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Intellipharmaceutics International stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on OTC:IPCIF stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Intellipharmaceutics International stock?
To sell your OTC:IPCIF stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Intellipharmaceutics International stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading OTC:IPCIF stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
| |
Our score |
0% commission |
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
Reportlab Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 Reportlab.Finance | All rights reserved.
-logo.jpg){kind=logo}
